Covance gets into lab management; CuriRx lands National Cancer Institute deal;

> Covance ($COV) is now offering lab management services, aiding its clients in vetting, selecting and overseeing external labs during development. News

> CRO CuriRx landed a 5-year deal with the National Cancer Institute to develop and produce dose forms for studies. Item

> WCCT Global has launched a mobile-phone-friendly patient recruitment system. More